Cantel Medical acquires Siemens’ hemodialysis water business

US-based Cantel Medical, through its subsidiary Mar Cor Purification, has purchased the hemodialysis water business from Siemens’ Water Technologies’ business unit.

Cantel acquired the business as part of its strategy to expand its water purification and filtration business and extend Mar Cor Purification’s footprint in the US and Canada.

The acquisition is expected to increase Cantel Medical’s earnings per share in fiscal year 2013 and beyond.

Mar Cor Purification president and CEO Curtis Weitnauer said that the company will continue to expand its business and provide dialysis products and services to its existing and new customers.

"The acquisition of the Siemens hemodialysis water customer base enables Mar Cor to realise increased efficiencies from our existing field service operations while also expanding our footprint into new geographies," Weitnauer added.

"With this geographic expansion, Mar Cor will further improve its ability to service its large national customers."

Cantel Medical president and CEO Andrew Krakauer said the company is confident of growing its water purification and filtration business.

"Our advanced heat-based disinfection water technology coupled with our nationwide service footprint makes Mar Cor the best choice for infection prevention and control to our dialysis customers," Krakauer added.

With the acquisition of Siemens’ hemodialysis water business, the company is expecting to further strengthen its position in the market as a provider of water purification products.

Cantel Medical is a provider of infection prevention and control products in the healthcare market, while its subsidiary Mar Cor Purification focuses on innovative solutions through filtration, water purification, and disinfection technologies for the medical, life science and industrial market.

---

Image: Siemens headquarters in Munich, Germany. Photo: Courtesy of Rufus46.